Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DANIEL NATHANIEL EFIOM-EKAHA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1396783122
CMS profile
18209
Location
YORK, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$88,870.51

101 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DANIEL NATHANIEL EFIOM-EKAHA

NPI 1396783122 · CMS profile ID 18209

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

YORK, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396783122?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DANIEL NATHANIEL EFIOM-EKAHA, NPI 1396783122, CMS profile ID 18209. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396783122?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). DANIEL NATHANIEL EFIOM-EKAHA, NPI 1396783122, CMS profile ID 18209. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396783122?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
DANIEL NATHANIEL EFIOM-EKAHA, NPI 1396783122, CMS profile ID 18209, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 101 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1396783122?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

101 matching records · $88,870.51 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 101 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 101.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BeiGene USA, Inc. $75.0006/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187227 CMS
GENZYME CORPORATION $12.3106/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049967231 CMS
BeiGene USA, Inc. $11.6106/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187195 CMS
Gilead Sciences, Inc. $10.9406/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026065221 CMS
GENZYME CORPORATION $1,964.0006/15/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049967243 CMS
BeiGene USA, Inc. $87.5006/14/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187217 CMS
BeiGene USA, Inc. $106.4706/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187219 CMS
BeiGene USA, Inc. $3,900.0006/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187221 CMS
Pharmacosmos Therapeutics Inc. $170.1506/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046247339 CMS
Pharmacosmos Therapeutics Inc. $85.9606/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046247313 CMS
Pharmacosmos Therapeutics Inc. $118.8406/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046247321 CMS
Pharmacosmos Therapeutics Inc. $109.1506/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046247331 CMS
E.R. Squibb & Sons, L.L.C. $9.9006/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016078659 CMS
Pharmacosmos Therapeutics Inc. $170.1506/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046247291 CMS
Pharmacosmos Therapeutics Inc. $634.9606/01/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046247299 CMS
Rigel Pharmaceuticals, Inc. $11.2905/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033397187 CMS
PFIZER INC. $9.6705/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050353991 CMS
BeiGene USA, Inc. $77.8805/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187205 CMS
BeiGene USA, Inc. $195.0005/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187207 CMS
BeiGene USA, Inc. $5,200.0005/17/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187209 CMS
BeiGene USA, Inc. $68.7505/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187211 CMS
BeiGene USA, Inc. $125.0005/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187213 CMS
BeiGene USA, Inc. $3,900.0005/11/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187215 CMS
US Oncology Corporate, Inc. $61.0205/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027222523 CMS
Janssen Biotech, Inc. $420.0004/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988432681 CMS
AstraZeneca Pharmaceuticals LP $13.1404/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015069589 CMS
TAIHO ONCOLOGY, INC. $1,800.0004/07/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055231793 CMS
BeiGene USA, Inc. $3,900.0003/29/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187199 CMS
BeiGene USA, Inc. $80.0003/29/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187201 CMS
BeiGene USA, Inc. $93.8903/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187203 CMS
GENZYME CORPORATION $9.1303/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049967143 CMS
BeiGene USA, Inc. $12.1603/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187197 CMS
Rigel Pharmaceuticals, Inc. $9.4803/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033380987 CMS
BeiGene USA, Inc. $66.0002/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187243 CMS
BeiGene USA, Inc. $73.0802/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187253 CMS
BeiGene USA, Inc. $252.8702/16/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187255 CMS
E.R. Squibb & Sons, L.L.C. $10.6602/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016078575 CMS
ARRAY BIOPHARMA INC $13.8402/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049511209 CMS
TAIHO ONCOLOGY, INC. $8.7702/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055234125 CMS
BeiGene USA, Inc. $6,500.0002/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187245 CMS
GENZYME CORPORATION $9.0602/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049967131 CMS
US Oncology Corporate, Inc. $86.1902/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027222517 CMS
E.R. Squibb & Sons, L.L.C. $9.9801/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016078571 CMS
BeiGene USA, Inc. $41.8001/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187247 CMS
BeiGene USA, Inc. $49.8701/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187249 CMS
BeiGene USA, Inc. $49.8701/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187251 CMS
BeiGene USA, Inc. $458.5801/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051187257 CMS
AstraZeneca Pharmaceuticals LP $60.1501/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011266595 CMS
AstraZeneca Pharmaceuticals LP $103.8001/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011420753 CMS
PFIZER INC. $7.0801/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050307959 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $29,818.90 92
PY2020 $44,273.20 93
PY2021 $37,180.90 84
PY2022 $33,339.35 80
PY2023 $88,870.51 101
PY2024 $56,790.47 70
PY2025 $55,479.17 64

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $918.62 6
PY2025 Principal investigator $4,220.25 4
PY2024 Principal investigator $8,149.80 5
PY2023 Principal investigator $9,667.20 9
PY2022 Principal investigator $5,709.03 3
PY2021 Principal investigator $14,497.95 30
PY2020 Principal investigator $229,343.30 56
PY2019 Principal investigator $10,850.00 69

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ARRAY BIOPHARMA INC $1,000.00 06/11/2025 Non-covered Recipient Entity
WELLSPAN HEALTH
A PHASE 2 OPENLABEL STUDY OF ENCORAFENIB BINIMETINIB IN PATIENTS WITH BRAFV600MUTANT NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228791759
Recipient ABBVIE INC. $261.22 05/30/2025 Covered Recipient Physician A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202398026
Recipient ABBVIE INC. $48.00 05/30/2025 Covered Recipient Physician A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202398031
Recipient ABBVIE INC. $47.37 05/30/2025 Covered Recipient Physician A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202398036
Recipient ABBVIE INC. $25.00 05/30/2025 Covered Recipient Physician A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202398039
Recipient ABBVIE INC. $144.91 05/29/2025 Covered Recipient Physician A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202398018
Recipient ABBVIE INC. $392.12 05/29/2025 Covered Recipient Physician A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1202398022
Principal investigator 1 ARRAY BIOPHARMA INC $1,803.75 04/18/2025 Non-covered Recipient Entity
WELLSPAN HEALTH
A PHASE 2 OPENLABEL STUDY OF ENCORAFENIB BINIMETINIB IN PATIENTS WITH BRAFV600MUTANT NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228793645
Principal investigator 1 ARRAY BIOPHARMA INC $916.50 04/16/2025 Non-covered Recipient Entity
WELLSPAN HEALTH
A PHASE 2 OPENLABEL STUDY OF ENCORAFENIB BINIMETINIB IN PATIENTS WITH BRAFV600MUTANT NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228780065
Principal investigator 1 ARRAY BIOPHARMA INC $500.00 02/12/2025 Non-covered Recipient Entity
WELLSPAN HEALTH
A PHASE 2 OPENLABEL STUDY OF ENCORAFENIB BINIMETINIB IN PATIENTS WITH BRAFV600MUTANT NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228794104